Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hercules Capital (NYSE: HTGC) is a leading specialty finance company focused on providing senior secured loans to high-growth, innovative venture capital-backed companies in the life sciences, technology, and renewable energy sectors. The Hercules Venture Growth Credit Opportunities Fund 1 is a specialized investment vehicle managed by the firm to provide debt financing to late-stage venture and growth-stage companies. The fund specifically targets the healthcare and biotechnology industries, offering non-dilutive capital solutions that help companies fund clinical trials and commercialization efforts. Since its inception, the broader Hercules organization has committed billions of dollars to hundreds of life science companies, making it a pivotal player in the biotech financing ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hercules Venture Growth Credit Opportunities Fund 1.